Tokyo Tape
Sign in
← Meiji Holdings

Quarterly report · Q3

2269.TEDINET S100SSKZ
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥833.0bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥1.06T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥798.1bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥69.7bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥64.7bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥68.3bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥74.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥66.4bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥74.0bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥69.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥44.9bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥69.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥47.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥48.4bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥49.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥1.24Tat 2023-12-31Cons.Assets
Total assets¥1.14Tat 2023-03-31Cons.Assets
Total assets¥1.21Tat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥442.5bnat 2023-12-31Cons.Liabilities
Total liabilities¥384.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥793.5bnat 2023-12-31Cons.Net assets
Net assets / equity¥751.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥748.1bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥92.3bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥63.5bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥88.5bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥85.9bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥64.5bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥85.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥36.7bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥29.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥36.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥41.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥10.6bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥54.7bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥21.3bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥161.132023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥612023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥247.392022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥168.122022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥49.572022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio60.8%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio58.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥579m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥579m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥1.7bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue2023-04-01 → 2023-12-31¥679.5bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue external2023-04-01 → 2023-12-31¥678.9bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥563m
jpcrp040300-q3r_E21902-000Foodreportable segmentsegment profit2023-04-01 → 2023-12-31¥48.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue2023-04-01 → 2023-12-31¥154.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue external2023-04-01 → 2023-12-31¥154.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥16m
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentsegment profit2023-04-01 → 2023-12-31¥22.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥833.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥833.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥579m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥71.5bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥557m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥557m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.4bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue2022-04-01 → 2022-12-31¥649.9bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue external2022-04-01 → 2022-12-31¥649.4bn
jpcrp040300-q3r_E21902-000Foodreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥542m
jpcrp040300-q3r_E21902-000Foodreportable segmentsegment profit2022-04-01 → 2022-12-31¥45.1bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue2022-04-01 → 2022-12-31¥148.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue external2022-04-01 → 2022-12-31¥148.7bn
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥14m
jpcrp040300-q3r_E21902-000Pharmaceuticalreportable segmentsegment profit2022-04-01 → 2022-12-31¥21.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥798.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥798.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥557m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥66.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 514
ItemContextValueUnit
Other elCurrentYTDDuration1615000000JPY
Extraordinary lossPrior1YTDDuration6188000000JPY
Extraordinary lossCurrentYTDDuration4824000000JPY
Income before income taxesPrior1YTDDuration69001000000JPY
Income before income taxesCurrentYTDDuration74030000000JPY
Income taxesPrior1YTDDuration19440000000JPY
Income taxesCurrentYTDDuration25625000000JPY
Profit lossPrior1YTDDuration49560000000JPY
Profit lossCurrentYTDDuration48404000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration2277000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration3458000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration47283000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration44946000000JPY
Profit lossPrior1YTDDuration49560000000JPY
Profit lossCurrentYTDDuration48404000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-2437000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration4678000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration-139000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration-35000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration14132000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration12379000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration1731000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration239000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration7919000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration2811000000JPY
Other comprehensive incomePrior1YTDDuration21206000000JPY
Other comprehensive incomeCurrentYTDDuration20074000000JPY
Comprehensive incomePrior1YTDDuration70767000000JPY
Comprehensive incomeCurrentYTDDuration68479000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration68446000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration64912000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration2321000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration3566000000JPY
Income before income taxesPrior1YTDDuration69001000000JPY
Income before income taxesCurrentYTDDuration74030000000JPY
Depreciation and amortization ope cfPrior1YTDDuration39828000000JPY
Depreciation and amortization ope cfCurrentYTDDuration41246000000JPY
Impairment loss ope cfPrior1YTDDuration239000000JPY
Impairment loss ope cfCurrentYTDDuration620000000JPY
Amortization of goodwill ope cfPrior1YTDDuration11000000JPY
Amortization of goodwill ope cfCurrentYTDDuration11000000JPY
Loss on retirement of property plant and equipment ope cfPrior1YTDDuration2485000000JPY
Loss on retirement of property plant and equipment ope cfCurrentYTDDuration2691000000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-15000000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration31000000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration-5862000000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration-5634000000JPY
Increase decrease in net defined benefit liability ope cfPrior1YTDDuration4391000000JPY
Increase decrease in net defined benefit liability ope cfCurrentYTDDuration710000000JPY
Interest and dividends income ope cfPrior1YTDDuration-1681000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass